INSIDE INFORMATION Combining arsenic and a metal ion decreases dosage needed for therapeutic effects in preclinical chronic graft-versus-host disease and systemic sclerosis models . | June 20, 2023
INSIDE INFORMATION Combining arsenic and a metal ion decreases dosage needed for therapeutic effects in preclinical chronic graft-versus-host disease and.
INSIDE INFORMATION Maintenance of the license is now subject to the launch of the OATO Phase III before May 2024 instead of 31 May 2023 Parties also currently negotiating a potential renegotiation. | May 29, 2023
INSIDE INFORMATION Potential license agreement to produce and commercialize original and transformed ALLOB cells BioSenic to potentially receive royalty.